103: An Interview With Dr. Paul Bolno, CEO of Wave Life Sciences
Episode Ep 103 10 min 28s

103: An Interview With Dr. Paul Bolno, CEO of Wave Life Sciences

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Paul Bolno, MD, the CEO of Wave Life Sciences, whose investigational therapy WVE-006 is a potential treatment for the liver disease associated with alpha-1 antitrypsin disorder (AATD).

Community discussion